Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemist and Druggist (C+D) is a leading media brand and information provider dedicated to the community pharmacy sector in the United Kingdom. Founded in 1859, the organization provides news, clinical resources, and business intelligence to pharmacists and healthcare professionals. The company offers a comprehensive digital platform that includes professional development modules, regulatory updates, and market insights. Additionally, C+D operates a specialized recruitment service and provides data solutions to help pharmaceutical manufacturers engage with the pharmacy industry. It is currently owned by Communications International Group following its acquisition from Informa in 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemist and Druggist.